Empowered Patient Podcast

Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys

Informações:

Synopsis

Kathy Lee-Sepsick, President, Founder, and CEO of Femasys, uses innovative medical technologies to address unmet women's reproductive healthcare needs. Femasyis is developing treatments for infertility and birth control and diagnostic tools to support its treatment offerings. The devices are intentionally designed to be more accessible, less invasive, and safer for women than existing options, some of which have not changed in 100 years.   Kathy explains, "Our technologies are just for women. So, we include broad categories of women. And we did this, particularly with the FemBloc product that we're advancing. It's a non-surgical permanent birth control solution for women that is delivered in the office. No anesthesia, no incisions, no hormones, no implants, none of the things that come par for the course for what's out there right now. And we included in our patient population women who did not have children before, which had never been done before." "So, there've been other technologies that have come and